Signal 1 comprises antigen recognition mediated through the T‐cell receptor and trigged by DCs cross‐presentation of tumor antigens on MHC I or MHC II molecules to CD8+ T cells and CD4+ T cells, respectively (Fig. 3). The gene discussed is CD8A; the disease is neoplasm.